Masaki Iino

11PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersHaematologyCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 28, 2026
A Survey Study of Patient-Physician Communication and Treatment Decision-Making Preference at Treatment Initiation and After Disease Stabilization in Newly Diagnosed Multiple Myeloma.

|Aug 19, 2025
Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Hiroki Yamaguchi, Masaki Iino, Shugo Kowata

|May 20, 2025
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Hiroki Yamaguchi, Masaki Iino, Shugo Kowata

|Mar 01, 2024
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.

Yasunori Kogure, Hiroshi Handa, Yuta Ito

|Feb 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study).

Yu Abe, Shiro Kubonishi, Masaki Ri

|Jun 25, 2022
Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis.

Masaki Iino, Tomoya Sato, Ayato Nakadate

Pageof 2

Frequent Collaborators

2 joint publications

Tomoki Ito

2 joint publications

Motoaki Shiratsuchi

2 joint publications

Kenji Yokoyama

2 joint publications

Yoshiaki Tomiyama